Cencora, Inc. (ABG)
FSX
Real-time Data
06:00 AM
Day's Range
289.1052 wk Range
171.00Overview - ABG - Cencora, Inc.
Key Statistics
Valuation
Enterprise Value
2.93T
P/E (Trailing)
‪17.14‬
PEG Ratio
‪0.05‬
Price / Sales (TTM)
‪8.03‬
Price / Book
‪6.71‬
EV / EBITDA
‪19.84‬
Profitability
Gross Margin
‪61.64%‬
Profit Margin
‪54.77%‬
Operating Margin
‪34.03%‬
Return on Assets
‪12.95%‬
Return on Equity
‪48.67%‬
Ownership
Shares Outstanding
12.22B
Float
10.87B
Held by Insiders
‪0.52%‬
Held by Institutions
‪62.28%‬
Price stats
Beta
‪1.23‬
50-Day Avg
‪305.69‬
200-Day Avg
‪286.95‬
Dividends
Payout Ratio
‪4.26%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ABG - Cencora, Inc.
Peers - ABG - Cencora, Inc.
Peer Comparison
Compared with companies in Medical Distribution listed on FSX.
Profile Summary - ABG - Cencora, Inc.
About
Cencora, Inc. is a leading global pharmaceutical solutions organization that distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and equipment to healthcare providers worldwide. It serves acute care hospitals, health systems, independent and chain retail pharmacies, mail-order…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
